@article{AMJ3998,
author = {Alexey V. Aksenov and Klaus-Peter Jünemann and Daniar K. Osmonov},
title = {Editorial on “Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer”},
journal = {AME Medical Journal},
volume = {2},
number = {8},
year = {2017},
keywords = {},
abstract = {Most urologists who treat prostate cancer (PCa) patients are familiar with the well-known Briganti nomograms. According to the EAU guidelines on PCa (1), the indications for nodal sampling by means of extended pelvic lymph nodes (LNs) dissection (ePLND) are high-risk and intermediate-risk PCa with a risk of nodal metastases of over 5% according to the Briganti nomogram or MSKCC (2-4).},
issn = {2520-0518}, url = {https://amj.amegroups.org/article/view/3998}
}